Single Cell Genome Sequencing Market Determine a Spectacular Expansion And Productive Impact 2018-2026 Global Players are Fludigim Corporation, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd.

Single Cell Genome Sequencing Market - Competitive Landscape:

Key players operating in the single cell genome sequencing market include, Illumina, Inc., Fludigim Corporation, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Inc., QIAGEN, Bio-Rad Laboratories, 10x Genomics, Novogene, BGI, Oxford Nanopore Technologies, and Pacific Biosciences

To know more about the key players in this market, get in Touch With us for a FREE sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/2059

Single cell genome sequencing involves isolating a single cell and amplifying and sequencing genes within that single cell. Sequencing single cell carries significant importance as individual cells can differ at great extent in size, protein levels, and expressed RNA transcripts. These variations could provide important insights about several research applications such as cancer research, stem cell biology, immunology, developmental biology, and neurology. Single-cell analysis enables a closer view of the gene expression of individual cells to understand their functions in complex tissues.

Kits and instruments based on technological platform such as Next Generation Sequencing (NGS), polymerase chain reaction (PCR), quantitative polymerase chain reaction (qPCR), and others provide high-throughput sequencing of individual cells. Single cell sequencing has significantly evolved with in-depth understanding of genomes and increasing genomic research to trace the root cause of many chronic diseases.

Single Cell Genome Sequencing Market Dynamics:

Single cell genome sequencing is one of most focused area of research for finding cure for chronic disease such as cancer as it could help to observe tumor microenvironment. According to World Health Organization (WHO), cancer is one of leading non-communicable disease and second leading cause of death, worldwide. According to a report by International Age for Research on Cancer (IARC) in 2012, around 14.1 million new cases of cancer were registered with around 8.8 million death and around 32.6 million people are living with cancer in the year 2012.

Introduction of new therapies for the treatment of cancer such as personalized medicine (Immuno-oncology and others.) is expected to increase the adaption of single cell genomic sequencing for advancing research in order to observe cellular level changes in cancer cells.

Application of single cell genomic sequencing in other diseases such as immune system disorder and infectious diseases (Tuberculosis, meningococcal disease, and others.) is a key factor contributing to the market growth. According to statistics given by Centers for Disease Control and Prevention 2017 Vital Signs, around 54.4 million U.S. adults suffer from arthritis – which is equivalent to 25% of the U.S. population. Rheumatoid arthritis which is leading autoimmune disorder holds significant share in the overall arthritis prevalence.

Continuous development in sequencing technologies is further expected to propel growth of the single cell genome sequencing market. PCR and next generation sequencing are rapidly emerging as preferred technology for several applications including single cell genomic sequencing. For instance, Oxford Nanopore, in 2017, launched two sequencing kits— for direct or PCR cDNA analysis that facilitate easy use and provide results in reduced time and cost.

Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/single-cell-genome-sequencing-market-2059

Single Cell Genome Sequencing Market - Regional Insights:

On the basis of Geography, single cell genome sequencing market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be dominant in the market during forecast period. High prevalence of different types of cancer is witnessed in the U.S. According to a report by American cancer Society, 2018, cancer is the second leading cause of death after cardio vascular disease. The report further projected around 1.7 million new cases of cancer with around half million deaths, worldwide.

Single cell genome sequencing is utilized by several research institutes and commercial companies for revealing changes at gene level in single cell which could lead to potential therapies and access to develop new medicines.

Moreover, key players that offer cutting edge technologies such as NGS technology, q PCR technology and high commercial and academic research spending are present in the U.S, which is expected to accelerate the market growth.

Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2059

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.